Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.17 USD -8.59% Market Closed
Market Cap: 215.4m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Nektar Therapeutics
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nektar Therapeutics
Total Assets Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Nektar Therapeutics
NASDAQ:NKTR
Total Assets
$343.3m
CAGR 3-Years
-37%
CAGR 5-Years
-30%
CAGR 10-Years
-3%
Johnson & Johnson
NYSE:JNJ
Total Assets
$178.3B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Total Assets
$93.7B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Total Assets
$216.2B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Total Assets
$117.5B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Total Assets
$75.6B
CAGR 3-Years
16%
CAGR 5-Years
15%
CAGR 10-Years
8%

See Also

What is Nektar Therapeutics's Total Assets?
Total Assets
343.3m USD

Based on the financial report for Jun 30, 2024, Nektar Therapeutics's Total Assets amounts to 343.3m USD.

What is Nektar Therapeutics's Total Assets growth rate?
Total Assets CAGR 10Y
-3%

Over the last year, the Total Assets growth was -31%. The average annual Total Assets growth rates for Nektar Therapeutics have been -37% over the past three years , -30% over the past five years , and -3% over the past ten years .

Back to Top